Imaging correlates of pathology in corticobasal syndrome

Neurology

Volumn 75, Issue 21, 2010, Pages 1879-1887

  Whitwell, J L ^a   Jack, C R ^a   Boeve, B F ^a   Parisi, J E ^a   Ahlskog, J E ^a   Drubach, D A ^a   Senjem, M L ^a   Knopman, D S ^a   Petersen, R C ^a   Dickson, D W ^b   Josephs, K A ^a  

^a MAYO CLINIC   (United States)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; ATLAS; AUTOPSY; BRAIN ATROPHY; CASE CONTROL STUDY; CEREBRAL PALSY; CORTICOBASAL DEGENERATION; CORTICOBASAL SYNDROME; DEGENERATIVE DISEASE; DEMOGRAPHY; DISEASE COURSE; FEMALE; FRONTOTEMPORAL DEMENTIA; GENDER; GRAY MATTER; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; INSULA; MALE; MORPHOMETRICS; MOTOR CORTEX; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PARIETAL LOBE; POSTSYNAPTIC POTENTIAL; PREFRONTAL CORTEX; PREMOTOR CORTEX; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; VOXEL BASED MORPHOMETRY;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; ATROPHY; BASAL GANGLIA; BRAIN DISEASES; CADAVER; CASE-CONTROL STUDIES; CEREBRAL CORTEX; DNA-BINDING PROTEINS; FEMALE; FRONTAL LOBE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MOTOR CORTEX; PARIETAL LOBE; PERIAQUEDUCTAL GRAY; PREFRONTAL CORTEX; SUPRANUCLEAR PALSY, PROGRESSIVE; SYNDROME; TEMPORAL LOBE;

EID: 78649994826     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e3181feb2e8     Document Type: Article

References (40)

1. Boeve BF, Lang AE, Litvan I. Corticobasal degeneration and its relationship to progressive supranuclear palsy and frontotemporal dementia. Ann Neurol 2003;54(suppl 5): S15-S19.
2. Riley DE, Lang AE, Lewis A, et al. Cortical-basal ganglionic degeneration. Neurology 1990;40:1203-1212.
3. Boeve BF, Maraganore DM, Parisi JE, et al. Pathologic heterogeneity in clinically diagnosed corticobasal degeneration. Neurology 1999;53:795-800.
4. Hu WT, Rippon GW, Boeve BF, et al. Alzheimer's disease and corticobasal degeneration presenting as corticobasal syndrome. Mov Disord 2009;24:1375-1379.
5. Shelley BP, Hodges JR, Kipps CM, et al. Is the pathology of corticobasal syndrome predictable in life? Mov Disord 2009;24:1593-1599.
6. Mackenzie IR, Neumann M, Bigio EH, et al. Nomenclature and nosology for neuropathologic subtypes of frontotemporal lobar degeneration: An update. Acta Neuropathol 2010;119:1-4.
7. Neumann M, Sampathu DM, Kwong LK, et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 2006;314:130-133.
8. Boxer AL, Geschwind MD, Belfor N, et al. Patterns of brain atrophy that differentiate corticobasal degeneration syndrome from progressive supranuclear palsy. Arch Neurol 2006;63:81-86.
9. Hassan A, Whitwell JL, Boeve BF, et al. Symmetric corticobasal degeneration (S-CBD). Parkinsonism Relat Disord 2010;16:208-214.
10. Josephs KA, Whitwell JL, Dickson DW, et al. Voxel-based morphometry in autopsy proven PSP and CBD. Neurobiol Aging 2008;29:280-289.
11. Josephs KA, Whitwell JL, Boeve BF, et al. Anatomical differences between CBD and Alzheimer's disease presenting as corticobasal syndrome. Mov Disord 2010;25:1246-1252.
12. Whitwell JL, Jack CR Jr, Przybelski SA, et al. Temporoparietal atrophy: A marker of AD pathology independent of clinical diagnosis. Neurobiol Aging Epub 2009 Nov 13.
13. Whitwell JL, Jack CR Jr, Boeve BF, et al. Voxel-based morphometry patterns of atrophy in FTLD with mutations in MAPT or PGRN. Neurology 2009;72:813-820.
14. Lezak M. Neuropsychological Assessment, 4th ed. New York: Oxford University Press; 2004.
15. Mirra SS, Heyman A, McKeel D, et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD): Part II: Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 1991;41:479-486.
16. Mackenzie IR, Neumann M, Bigio EH, et al. Nomenclature for neuropathologic subtypes of frontotemporal lobar degeneration: Consensus recommendations. Acta Neuropathol 2009;117:15-18.
17. Mackenzie IR, Baborie A, Pickering-Brown S, et al. Heterogeneity of ubiquitin pathology in frontotemporal lobar degeneration: Classification and relation to clinical phenotype. Acta Neuropathol 2006;112:539-549.
18. Hauw JJ, Daniel SE, Dickson D, et al. Preliminary NINDS neuropathologic criteria for Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy). Neurology 1994;44:2015-2019.
19. Dickson DW, Bergeron C, Chin SS, et al. Office of Rare Diseases neuropathologic criteria for corticobasal degeneration. J Neuropathol Exp Neurol 2002;61:935-946.
20. The National Institute on Aging, and Reagan Institute Working Group on Diagnostic Criteria for Neuropathologic Assessment of Alzheimer's Disease. Consensus recommendation for the postmortem diagnosis of Alzheimer's disease. Neurobiol Aging 1997;18(suppl 1): S1-S2.
21. Josephs KA, Tang-Wai DF, Edland SD, et al. Correlation between antemortem magnetic resonance imaging findings and pathologically confirmed corticobasal degeneration. Arch Neurol 2004;61:1881-1884.
22. Ashburner J, Friston KJ. Voxel-based morphometry-the methods. Neuroimage 2000;11:805-821.
23. Ashburner J, Friston KJ. Unified segmentation. Neuroimage 2005;26:839-851.
24. Whitwell JL, Jack CR Jr, Senjem ML, et al. MRI correlates of protein deposition and disease severity in postmortem frontotemporal lobar degeneration. Neurodegener Dis 2009;6:106-117.
25. Tzourio-Mazoyer N, Landeau B, Papathanassiou D, et al. Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain. Neuroimage 2002;15:273-289.
26. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state": A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198.
27. Hughes CP, Berg L, Danziger WL, et al. A new clinical scale for the staging of dementia. Br J Psychiatry 1982;140: 566-572.
28. Kelley BJ, Haidar W, Boeve BF, et al. Prominent phenotypic variability associated with mutations in Progranulin. Neurobiol Aging 2009;30:739-751.
29. Braak H, Del Tredici K, Rub U, et al. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging 2003;24:197-211.
30. Whitwell JL, Jack CR Jr, Senjem ML, Josephs KA. Patterns of atrophy in pathologically confirmed FTLD with and without motor neuron degeneration. Neurology 2006; 66:102-104.
31. Whitwell JL, Josephs KA, Rossor MN, et al. Magnetic resonance imaging signatures of tissue pathology in frontotemporal dementia. Arch Neurol 2005;62:1402-1408.
32. Whitwell JL, Jack CR Jr, Baker M, et al. Voxel-based morphometry in frontotemporal lobar degeneration with ubiquitin-positive inclusions with and without progranulin mutations. Arch Neurol 2007;64:371-376. (Pubitemid 46425691)
33. Josephs KA, Ahmed Z, Katsuse O, et al. Neuropathologic features of frontotemporal lobar degeneration with ubiquitin-positive inclusions with progranulin gene (PGRN) mutations. J Neuropathol Exp Neurol 2007;66: 142-151.
34. Benussi L, Ghidoni R, Pegoiani E, et al. Progranulin Leu271LeufsX10 is one of the most common FTLD and CBS associated mutations worldwide. Neurobiol Dis 2009;33:379-385.
35. Masellis M, Momeni P, Meschino W, et al. Novel splicing mutation in the progranulin gene causing familial corticobasal syndrome. Brain 2006;129:3115-3123.
36. Dickson DW. Neuropathologic differentiation of progressive supranuclear palsy and corticobasal degeneration. Journal of neurology 1999;246(suppl 2):II6 -15.
37. Josephs KA, Boeve BF, Duffy JR, et al. Atypical progressive supranuclear palsy underlying progressive apraxia of speech and nonfluent aphasia. Neurocase 2005;11:283-296.
38. Tsuboi Y, Josephs KA, Boeve BF, et al. Increased tau burden in the cortices of progressive supranuclear palsy presenting with corticobasal syndrome. Mov Disord 2005;20: 982-988.
39. Litvan I, Agid Y, Calne D, et al. Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele- Richardson-Olszewski syndrome): Report of the NINDSSPSP international workshop. Neurology 1996;47:1-9.
40. Huey ED, Pardini M, Cavanagh A, et al. Association of ideomotor apraxia with frontal gray matter volume loss in corticobasal syndrome. Arch Neurol 2009;66:1274-1280.